2017: 9 Groundbreaking Developments Achieved with CRISPR

Regarded as one of the century’s most important discoveries, CRISPR/CAS9 genetic technology led to groundbreaking medical developments in 2017. Let us explore these studies together.
Video: What Is Crispr?
1.Crispr Became More Precise and Safer
Crispr performs gene editing in DNAby creating double-strand breaks. However, in some cases, Crispr targets other gene regions, causing abnormalities in the genome. When first developed, Crispr only allowed editing of the entire gene. A method developed in 2017 made it possible to alter a single nucleotide (the basic building block of DNA) in a gene. This offers great hope, particularly for treating genetic diseases. Single-nucleotide mutationsaccount for half of the 32 mutations known to be associated with human diseases.
2.Crispr Performed Gene Editing in a Human Embryo for the First Time
Researchers in the United States successfully performed genetic editing in embryos for the first time. Crispr was used to genetically edit embryos carrying a fatal inherited heart condition. The disease-causing mutation was eliminated in a large proportion of the embryos.
3.A Crispr Treatment Against Huntington Disease Was Developed
Huntington disease, also known as Huntington chorea, results from toxic protein accumulation in the brain and is caused by mutations in the huntingtin gene. An effective treatment method using crispr was successfully developed against this fatal neurological disease, which has no treatment and is inherited from a mother or father. Researchers managed to eliminate these mutations to a large extent in mice with Huntington disease. After 3 weeks, a reduction in toxic proteins in the mice’s brains was observed. This study will also provide important guidance for developing similar treatments against other neurological diseases.
4. A Gene Editing Method Began to Be Tested in a Patient for the First Time
In the United States, a 44-year-old patient began receiving gene editing treatment for the first time. The therapy uses the Talen method, which is similar to crispr technology. Researchers aimed to correct mutations in a patient with a rare metabolic disease. The same research group is working on a gene editing method intended to eliminate HIV.
5. The First Semisynthetic Bacterium Was Developed with Crispr
Researchers designed a bacterium containing different nucleotides using Crispr genetic technology. Alongside the usual 4 types of nucleotides, the semisynthetic bacterium contains 2 new nucleotides. The bacteria developed in the study were observed not to pose any safety hazard.
6. Crispr Enabled Antibiotic-Resistant Bacteria to Destroy Themselves
By adding an antibiotic-resistance gene sequence to viruses, bacteria were made to destroy themselves. This development offers an effective treatment possibility against antibiotic-resistant bacteria, which cause substantial loss of life. Pills containing the CRISPR/CAS9 system may replace antibiotics in the future.
7. Tumor Growth Was Stopped by Using Crispr to Target Fusion Mutations Frequently Seen in Cancer
Mutations resulting from the fusion of two genes are common in cancer. Using a method resembling cut and paste, substantial tumor shrinkage was observed in mouse models of prostate and liver cancer.
8. Cancer Cell Growth Was Slowed with Crispr
Researchers managed to reduce the growth rate of rapidly growing tumors by targeting TUDOR-SN, an important gene in cancer cell proliferation. This method may pave the way for effective cancer treatments.
9. Crispr-Modified Pigs Paved the Way for Their Use in Human Organ Transplants
The main problem in human organ transplantation is a shortage of donors. In recent years, the idea of transplanting organs from animals such as pigs into humans has gained prominence. However, some viruses in pigs could be transferred with the organ, risking serious diseases in humans. Researchers successfully eliminated these viruses by using Crispr to intervene in pig embryos. All 37 genetically modified pigs were healthy and free of the viruses. This development will enable pigs to be used in human organ transplantation.
Sources
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.
Nature. 2017
2. Niu D, Wei HJ, Lin L ve ark.
Yang L. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9.
Science. 2017
3. Su Yang, Shihua Li, Xiao-Jiang Li.
CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease.
J Clin Invest. 2017
4. Chen ZH, Yu YP, Zuo ZH ve ark.
Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene.
Nat Biotechnol. 2017
5. Elbarbary, Reyad A. et al.
Tudor-SN-Mediated Endonucleolytic Decay of Human-Cell microRNAs Promotes G1/S Phase Transition.
Science 2017
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.